Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dongjin Pharmaceutical is a South Korean healthcare company specializing in the development and manufacture of health functional foods and traditional herbal medicines. The company is most widely recognized for its flagship joint health supplement, Ho-Gwan-Won Premium, which utilizes Methylsulfonylmethane (MSM) and various herbal extracts to support bone and joint mobility. Dongjin operates manufacturing facilities that adhere to Good Manufacturing Practice (GMP) standards to ensure product quality and safety. Their business model focuses on the domestic Korean market, leveraging extensive marketing and celebrity endorsements to drive sales of wellness and geriatric health products. The company also produces a variety of red ginseng and agarwood-based supplements aimed at improving vitality and immune function.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dong-Jin Pharmaceutical.